Q3 2025 Becton Dickinson and Co Earnings Call Transcript
Key Points
- Becton Dickinson & Co (BDX) reported an 8.5% revenue growth to $5.5 billion, with a 3% organic growth rate.
- The company achieved a 54.8% adjusted gross margin, up 50 basis points year-over-year, and a 25.8% adjusted operating margin, up 60 basis points.
- BDX raised its earnings guidance by $0.18 at the midpoint, reflecting strong performance and strategic investments.
- The company announced a definitive agreement to separate its Biosciences and Diagnostics business, expected to unlock shareholder value.
- BDX's innovation pipeline is robust, with successful product launches like the FACSDiscover A8 and the BD Libertas Wearable Injector entering clinical trials.
- Market headwinds in China and certain subsegments of Pharm Systems, such as vaccines, continue to pose challenges.
- The company faces a significant tariff impact, with $90 million affecting Q4 and an anticipated $275 million impact in fiscal 2026.
- BDX's operating margin is expected to see a slight sequential step down in Q4 due to the timing of investments.
- The Life Sciences segment experienced a low single-digit decrease, impacted by market dynamics in China and Europe.
- Despite strong performance, the company remains cautious about macroeconomic factors and market volatility affecting future growth.
Hello and welcome to BD's third fiscal quarter 2025 earnings call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at (800) 839-1246 for domestic calls and area code +1 (402) 220-7203 for international calls.
(Operator Instructions)
I will now turn the call over to Greg Rodetis, Senior Vice President, Treasurer, and Head of Investor Relations.
Good morning and welcome to BD's earnings call. I'm Greg Rodetis, Senior Vice President, Treasurer, and Head of Investor Relations. Thank you for joining us. This call is being made available via audio webcast at bd.com.
Earlier this morning, BD released its results for the third quarter of fiscal 2025. The press release and presentation can be accessed on the IR website at investors.bd.com.
Leading today's caller, Tom Poland, BD's Chairman, Chief Executive Officer, and President, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
